Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
GSK Keeps Oncology 2.0 Growth Plans On Track
Jun 04 2020
•
By
Mandy Jackson
GSK's strategy includes immuno-oncology, synthetic lethality, cell and gene therapy, and epigenetics • Source: Shutterstock
More from Anticancer
More from Therapy Areas